C21 Investments Inc. (CWLXF): Gross Profit

Annual figures by period end, from SEC filings.

$13.61M
Year ended 2026-03-31
$18.81M2021-01-31: $18.05M2022-01-31: $18.81M2023-01-31: $13.40M2024-01-31: $11.15M2025-03-31: $12.56M2026-03-31: $13.61M$13.61M
2021-01-31 Gross Profit (USD) 2026-03-31
Period endedGross ProfitChange YoYSource filing
2026-03-31$13.61M+8.3%2026-06-12, From 2025-04-01
2025-03-31$12.56Mn/a2026-06-12, From 2024-04-01
No annual figure between 2024-01-31 and 2025-03-31.
2024-01-31$11.15M-16.8%2025-06-23, From 2023-02-01
2023-01-31$13.40M-28.8%2024-08-08, From 2022-02-01
2022-01-31$18.81M+4.2%2023-07-28, From 2021-02-01
2021-01-31$18.05Mn/a2023-07-28, From 2020-02-01

Gross Profit at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
C21 Investments Inc. (CWLXF)2026-03-31$13.61M+8.3%
Leef Brands Inc. (LEEEF)2025-12-31$10.48M+36.5%
Synergy CHC Corp. (SNYRQ)2025-12-31$20.30M-14.1%
Cyanotech Corp (CYAN)2025-03-31$6.88M+15.7%
Charlie's Holdings, Inc. (CHUC)2025-12-31$5.66M+96.6%
Bon Natural Life Ltd (BON)2025-09-30$3.88M-45.4%
Fitlife Brands, Inc. (FTLF)2025-12-31$31.45M+12.0%
Mannatech Inc (MTEX)2025-12-31$80.96M-11.5%
Niagen Bioscience, Inc. (NAGE)2025-12-31$83.19M+35.1%

Compare CWLXF, LEEEF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗